Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus? - Wikidata - awgldk - TriplyDB

Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?

Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?

http://www.wikidata.org/entity/Q41049740

about

Wolfram Syndrome: A Case Report and Review of Clinical Manifestations, Genetics Pathophysiology, and Potential Therapies.

P2860

Q55417859-CCB58B96-4705-4DC9-A08E-25E2556E916E

P2860

Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?

http://www.wikidata.org/entity/Q41049740

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?

@en

type

label

Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?

@en

prefLabel

Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?

@en

P1433

Q41049740-799DE39C-3F8D-49A7-8F17-7647142305EF

P1476

Q41049740-FDF5122A-9561-4931-BA76-2F54A6697D1B

P2093

Q41049740-A32BFE89-7505-4800-9D20-DF55F7123E28

P2860

Q41049740-04D0EC0A-2BE8-4624-80F1-F984FB13ED48

Q41049740-09223B63-8028-4381-A234-2D5C1D070EE7

Q41049740-1426C74A-2A06-4DC1-ADF2-6928F41B0D11

Q41049740-15E525D7-2033-4981-A2C1-27264142F89B

Q41049740-164F9FAF-97FD-45F3-A43C-B1EE0EFDF7C1

Q41049740-16EED59B-141F-46BE-846F-67F7C7843E94

Q41049740-22F22FA8-4DA7-4DFA-B80C-00D4D3E8B8BA

Q41049740-2DCB26E7-39B0-4820-B83E-8C2F6A5E169B

Q41049740-2EEFAE6D-7C4C-43D2-ABDE-79C85C4A9DC3

Q41049740-3AE63986-5F48-42F1-946A-770B1BF0D918

P304

Q41049740-87A45F1B-864E-47BD-B74A-D4D019761C90

P31

Q41049740-9DA9A838-FEFB-4788-8520-358D7D21038C

P356

Q41049740-71AFECBF-6EBD-4332-B006-BC891FB8D479

P478

Q41049740-BC054FF9-D9A1-4B87-AA07-AC5F572DAFE1

P50

Q41049740-3B3C5F08-9C0B-46B3-BB33-21722F5E18CD

P577

Q41049740-836DE565-308A-4271-8D01-2410D925A1F3

P698

Q41049740-870B8FBC-AFD8-4188-9F04-8DE56694FBF6

P932

Q41049740-AB78F568-4C75-4F0F-981B-50F4A9A05085

P356

FENDO.2017.00147

P1433

Frontiers in Endocrinology

P1476

Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?

@en

P2093

Aleksei Rakitin

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular and therapeutic potential and toxicity of valproic acid

Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitati

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia.

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.

Improving insulin sensitivity with HDAC inhibitor

Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial.

Valproate-induced insulin resistance and obesity in children.

Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

P304

147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FENDO.2017.00147

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28694790

http://www.w3.org/2001/XMLSchema#string

P932

5483554

http://www.w3.org/2001/XMLSchema#string